Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Carisoprodol

Till Conermann, Desirae Christian  1
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Book

Carisoprodol

Till Conermann et al.

Excerpt

Carisoprodol is an FDA-approved drug that relieves discomfort associated with acute, painful musculoskeletal conditions. Although marketed as a muscle relaxant, the parent compound is actually in the tranquilizer class of medications, with the primary metabolite being meprobamate, a benzodiazepine. Treating clinicians should assess patients for risk factors like substance abuse history and medication compliance when considering carisoprodol for pain and muscle spasms. In cases of overdose, emergency clinicians stabilize the patient, and severe cases may require critical care and toxicologist consultation or psychiatry referral for substance disorders.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Till Conermann declares no relevant financial relationships with ineligible companies.

Disclosure: Desirae Christian declares no relevant financial relationships with ineligible companies.

References

    1. Li Y, Delcher C, Brown JD, Wei YJ, Reisfield GM, Winterstein AG. Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis. Drug Alcohol Depend. 2019 Sep 01;202:172-177. - PubMed
    1. Reeves RR, Burke RS. Carisoprodol: abuse potential and withdrawal syndrome. Curr Drug Abuse Rev. 2010 Mar;3(1):33-8. - PubMed
    1. Horsfall JT, Sprague JE. The Pharmacology and Toxicology of the 'Holy Trinity'. Basic Clin Pharmacol Toxicol. 2017 Feb;120(2):115-119. - PubMed
    1. Wang Y, Delcher C, Li Y, Goldberger BA, Reisfield GM. Overlapping prescriptions of opioids, benzodiazepines, and carisoprodol: "Holy Trinity" prescribing in the state of Florida. Drug Alcohol Depend. 2019 Dec 01;205:107693. - PubMed
    1. Gonzalez LA, Gatch MB, Forster MJ, Dillon GH. Abuse Potential of Soma: the GABA(A) Receptor as a Target. Mol Cell Pharmacol. 2009 Jan 01;1(4):180-186. - PMC - PubMed

Publication types